ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100. A total of 165 filers reported holding ARIAD PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 0.75 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $47,000 | -76.5% | 3,460 | -76.3% | 0.00% | – |
| Q3 2016 | $200,000 | +952.6% | 14,592 | +467.3% | 0.00% | – |
| Q2 2016 | $19,000 | -48.6% | 2,572 | -56.4% | 0.00% | – |
| Q1 2016 | $37,000 | -77.7% | 5,901 | -77.7% | 0.00% | – |
| Q4 2015 | $166,000 | +315.0% | 26,469 | +294.6% | 0.00% | – |
| Q3 2015 | $40,000 | -4.8% | 6,708 | +34.2% | 0.00% | – |
| Q2 2015 | $42,000 | 0.0% | 5,000 | 0.0% | 0.00% | – |
| Q1 2015 | $42,000 | -89.9% | 5,000 | -91.7% | 0.00% | – |
| Q4 2014 | $414,000 | +37.5% | 60,300 | +8.2% | 0.00% | – |
| Q3 2014 | $301,000 | -37.7% | 55,750 | -26.4% | 0.00% | – |
| Q2 2014 | $483,000 | -52.3% | 75,750 | -39.8% | 0.00% | -100.0% |
| Q1 2014 | $1,013,000 | +147.7% | 125,750 | +109.8% | 0.00% | – |
| Q4 2013 | $409,000 | -90.2% | 59,950 | -73.6% | 0.00% | -100.0% |
| Q3 2013 | $4,185,000 | +38.6% | 227,412 | +31.7% | 0.01% | +40.0% |
| Q2 2013 | $3,020,000 | – | 172,634 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 12,850,000 | $82,111,000 | 18.09% |
| Consonance Capital Management LP | 5,575,742 | $35,629,000 | 5.39% |
| Opaleye Management Inc. | 1,250,000 | $7,988,000 | 4.98% |
| Tamarack Advisers, LP | 1,600,000 | $10,224,000 | 3.58% |
| Camber Capital Management LP | 5,405,235 | $34,539,000 | 2.02% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 324,636 | $2,074,000 | 1.36% |
| Palo Alto Investors LP | 2,248,317 | $14,367,000 | 1.12% |
| 1492 Capital Management LLC | 202,500 | $1,294,000 | 1.09% |
| Geduld E E | 120,100 | $767,000 | 1.05% |
| JS Capital Management LLC | 868,700 | $5,551,000 | 1.00% |